March 24-26, 2021 | 10:00AM EDT | 2:00PM UTC | 4:00PM CEST*
*Program is subject to change
Lipid metabolism provides the building blocks for cell growth and replication, signaling molecules that initiate and propagate signals inside and outside of cells, and fuel for cell function and division. The role of these molecular species in human disease has become more apparent with advancements in ability to detect and accurately quantify them. This meeting will integrate information generated through lipidomics studies. Specific areas of focus will include using genetic and proteomic data to identify changes in particular molecular species, the importance of changes in lipid metabolism and signaling and the regulatory enzymes for neurodegeneration, metabolic disorders, cancer and inflammation and immune responses. Featured talks will extend beyond methodologies to integrate the current biological and clinical importance of lipids with lipidomics approaches. This will allow us to focus upon the mechanistic importance of lipids in neurodegeneration and other neurological disorders, cancer, inflammation and metabolic disorders. By identifying enzymes that regulate changes in lipidomics, new targets for therapeutics can also be identified. This approach is inspired by PI3kinase, where the basic biochemistry has led to the development of effective inhibitors. We hope to discover other targets for lipid enzyme therapeutics. By moving towards lipid analysis and the biological and medical importance of lipid regulatory pathways, the goal is to use lipidomic profiling to get to better understand and treat different diseases. The majority of lipid related meetings focus on methodologies. We believe that PI3kinase should be reintegrated into meetings about lipid-related disease because it represents successful implementation of this approach. The PI3Kinase specific meeting is no longer attracting sufficient attendees but it remains an important scientific area for discussion. This meeting will also address the importance of particular lipid molecular as opposed to lipid classes. Modern lipidomic methodologies enabled us to identify more than 20,000 potential lipid species in a cell. There are particular species that regulate enzyme activities and membrane properties and thus functions like signaling and cellular migration. This meeting will include a workshop, led by members of LIPID MAPS, on lipidomics methodologies, data handling and storage to further emphasize the biological and medical importance of lipid diversity.
Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD
for Short Talk Consideration: February 10, 2021
ePoster Abstract Submission: March 10, 2021
Financial Aid Application: March 10, 2021
Graduate students and postdoctoral fellows, as well as individuals from low- and middle- income countries (all career stages) working in science and medicine related fields, are eligible to apply for a FREE registration code.
Find out more about financial aid opportunities here!
Showcase your work to global audiences on the eSymposia platform!
Submit your abstract for the opportunity to be selected for a short talk presentation alongside field leaders on the meeting program! See Abstract Deadline for Short Talk Consideration
ePoster presenters will be provided with their own dedicated page on the event website to display their work in multiple formats and interact with meeting participants. ePoster features include:
To submit your work for an ePoster presentation, and to be considered for short talk selection, go to the “Submit an Abstract” tab on the event homepage.
Speaking at this eSymposia
NHLBI, National Institutes of Health, USA
Vytas A. Bankaitis
Texas A&M University, USA
Simon T. Barry
Steffany A.L. Bennett
University of Ottawa, Canada
John E. Burke
University of Victoria, Canada
Christine Des Rosiers
Montreal Heart Institute (MHI), Canada
Gilbert Di Paolo
Denali Therapeutics Inc., USA
Eamonn James Dickson
University of California, Davis, USA
Gregory D. Fairn
University of Toronto, Canada
Weizmann Institute of Science, Israel
Harvard Medical School, USA
Phillip T. Hawkins
Babraham Institute, UK
Bruce D. Levy
Brigham and Women's Hospital, USA
Valerie B. O'Donnell
Cardiff University, UK
Julie D. Saba
University of California, San Francisco, USA
Mount Sinai, USA
Jean E. Schaffer
Joslin Diabetes Center, Harvard Medical School, USA
Virginia Commonwealth University, USA
Robert V. Stahelin
Purdue University, USA
Scott A. Summers
University of Utah, USA
Shanghai Institute of Nutrition and Health, China
Subscribe to receive updates to the program for this meeting.
Editors Attending This Meeting
Executive Editor, Journal of Experimental Medicine (JEM)
Gaia Trincucci, PhD
Scientific Editor, Journal of Experimental Medicine (JEM)
Céline Carret, PhD
Scientific Editor, EMBO Molecular Medicine
Zeljko Durdevic, PhD
Scientific Editor, EMBO Molecular Medicine
Denise Doolan, PhD
Specialty Chief Editor, Frontiers in Immunology
Alessandra Fornarelli, Dr. rer. nat.
Journal Manager, Frontiers in Immunology
Funding for this conference was made possible (in part) by 1R13CA246936-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.
Explore all cancer-related meetings on the Keystone Symposia website.